Literature DB >> 21567135

Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMS.

Wei Tian1, Tong Zhu, Jianhui Zhong, Xiang Liu, Praveen Rao, Benjamin M Segal, Sven Ekholm.   

Abstract

INTRODUCTION: Clinical trials of secondary progressive multiple sclerosis (SPMS) is lacking reliable biomarkers or outcome measures that reflect tissue injury incurred within a 1- to 2-year observation period. Diffusion tensor imaging (DTI) is sensitive in detecting acute brain tissue damage. We monitored SPMS patients over 12 months for diffusion changes within the corpus callosum (CC).
METHODS: Bimonthly MRI examinations over a 1-year period were performed on 11 SPMS patients. The protocol included postcontrast T1-weighted images and DTI. Based on the appearance of T1 enhancing lesion(s) during the study period, the patients were divided into enhancing (five patients) and nonenhancing (six patients) groups. Fractional anisotropy (FA) and mean diffusivity (MD) of the genu, body, and splenium of the CC were measured and temporal changes in mean FA and MD were evaluated for each group as well as between groups. Immunology data from peripheral blood mononuclear cells were also collected on a monthly basis.
RESULTS: The enhancing group showed significant, progressive decrease in FA in body (p = 0.012) and splenium (p = 0.033) of CC, and significantly higher lymphotoxin-β levels. No significant FA changes were seen in the nonenhancing group. Moreover, the FA decline in the enhancing group deviated significantly from the nonenhancing group, which remained essentially stable. Although MD increased slightly in both groups, there was no significant difference between the two groups.
CONCLUSION: Based on the MR and immunology findings, the results of our study suggest that DTI undergo more rapid and longitudinal changes in SPMS patients with inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567135     DOI: 10.1007/s00234-011-0885-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  31 in total

Review 1.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.

Authors:  C Bjartmar; J R Wujek; B D Trapp
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

2.  Fiber composition of the human corpus callosum.

Authors:  F Aboitiz; A B Scheibel; R S Fisher; E Zaidel
Journal:  Brain Res       Date:  1992-12-11       Impact factor: 3.252

3.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

4.  Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features.

Authors:  N Tubridy; A J Coles; P Molyneux; D A Compston; F Barkhof; A J Thompson; W I McDonald; D H Miller
Journal:  Brain       Date:  1998-02       Impact factor: 13.501

5.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

6.  MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis.

Authors:  J P Ranjeva; J Pelletier; S Confort-Gouny; D Ibarrola; B Audoin; Y Le Fur; P Viout; A Ali Chérif; P J Cozzone
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

7.  Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging.

Authors:  J Oh; R G Henry; C Genain; S J Nelson; D Pelletier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

8.  Lower fractional anisotropy at the anterior body of the normal-appearing corpus callosum in multiple sclerosis versus symptomatic carotid occlusion.

Authors:  Xin Lou; Weijian Jiang; Lin Ma; Ning Ma; Youquan Cai; Dehui Huang; Edward Hochung Wong
Journal:  Neuroradiology       Date:  2009-06-06       Impact factor: 2.804

9.  Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

Authors:  M Filippi; T Yousry; A Campi; C Kandziora; B Colombo; R Voltz; V Martinelli; S Spuler; S Bressi; G Scotti; G Comi
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

10.  Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials.

Authors:  F Barkhof; U Held; J H Simon; M Daumer; F Fazekas; M Filippi; J A Frank; L Kappos; D Li; S Menzler; D H Miller; J Petkau; J Wolinsky
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

View more
  8 in total

Review 1.  Automated detection of multiple sclerosis lesions in serial brain MRI.

Authors:  Xavier Lladó; Onur Ganiler; Arnau Oliver; Robert Martí; Jordi Freixenet; Laia Valls; Joan C Vilanova; Lluís Ramió-Torrentà; Alex Rovira
Journal:  Neuroradiology       Date:  2011-12-20       Impact factor: 2.804

Review 2.  Current and Future Biomarkers in Multiple Sclerosis.

Authors:  Jennifer Yang; Maysa Hamade; Qi Wu; Qin Wang; Robert Axtell; Shailendra Giri; Yang Mao-Draayer
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

3.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.

Authors:  Gloria C Chiang; Soniya Pinto; Joseph P Comunale; Susan A Gauthier
Journal:  J Neuroimaging       Date:  2015-10-13       Impact factor: 2.486

4.  Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in Sera.

Authors:  Renuka Natarajan; Sanna Hagman; Xingchen Wu; Ullamari Hakulinen; Minna Raunio; Mika Helminen; Maija Rossi; Prasun Dastidar; Irina Elovaara
Journal:  Mult Scler Int       Date:  2013-12-17

5.  Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.

Authors:  Lian Li; Michael Chopp; Siamak P Nejad-Davarani; Kourosh Jafari-Khouzani; Suresh C Patel; John Budaj; Mei Lu; Stanton B Elias; Mirela Cerghet; Quan Jiang
Journal:  J Neurol Neurophysiol       Date:  2014-04

6.  Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study.

Authors:  Marcin Kolasa; Ullamari Hakulinen; Antti Brander; Sanna Hagman; Prasun Dastidar; Irina Elovaara; Marja-Liisa Sumelahti
Journal:  Brain Behav       Date:  2018-12-26       Impact factor: 2.708

7.  Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.

Authors:  Serafeim Katsavos; Maria Anagnostouli
Journal:  Mult Scler Int       Date:  2013-01-22

Review 8.  Current status of biomarker research in neurology.

Authors:  Jiri Polivka; Jiri Polivka; Kristyna Krakorova; Marek Peterka; Ondrej Topolcan
Journal:  EPMA J       Date:  2016-07-04       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.